GOLPH2 mRNA has recently been described as an integral part of a multiplex marker to detect prostate cancer from urine samples that even outperformed a prostate-specific antigen (PSA) blood test (Laxman et al, 2008). The gene discussed is GOLM1; the disease is prostate carcinoma.